🇵🇱 Poland Country × Condition
glioblastoma Clinical Trials in Poland
Active clinical trials for glioblastoma with research sites in Poland. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇵🇱 Poland
Active Trials in Poland (2)
NCT07488754
Recruiting
Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) In Newly Diagnosed Glioma (WHO G3-G4)
Enrollment
35 pts
Country
🇵🇱 Poland
Medical University of Warsaw
View Trial → NCT07411690
Recruiting
Analysis of Cerebrospinal Fluid Leakage After Surgery for Intracranial Tumors
Enrollment
200 pts
Country
🇵🇱 Poland
Medical University of Warsaw
View Trial → Frequently Asked Questions
How many glioblastoma clinical trials are active in Poland?
There are currently 2 active clinical trials for glioblastoma with sites in Poland, of which 2 are actively recruiting patients.
How can I join a glioblastoma clinical trial in Poland?
To join a glioblastoma clinical trial in Poland, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Poland directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are glioblastoma trials in Poland?
Active glioblastoma trials in Poland span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology